LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 104 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545 | -52.4% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,145 | -5.8% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,215 | +27.2% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $955 | -4.5% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | -71.4% | 500 | -55.1% | 0.00% | – |
| Q2 2019 | $7,000 | +16.7% | 1,113 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | -14.3% | 1,113 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -46.2% | 1,113 | -5.6% | 0.00% | – |
| Q3 2018 | $13,000 | -97.3% | 1,179 | -97.1% | 0.00% | -100.0% |
| Q2 2018 | $484,000 | +32.6% | 40,337 | -5.4% | 0.00% | +50.0% |
| Q1 2018 | $365,000 | -12.3% | 42,643 | +1.3% | 0.00% | -33.3% |
| Q4 2017 | $416,000 | -20.2% | 42,100 | -0.7% | 0.00% | -25.0% |
| Q3 2017 | $521,000 | -26.1% | 42,385 | -1.2% | 0.00% | -33.3% |
| Q2 2017 | $705,000 | +19.1% | 42,885 | +3.9% | 0.01% | +20.0% |
| Q1 2017 | $592,000 | +9.0% | 41,270 | +5.0% | 0.01% | -16.7% |
| Q4 2016 | $543,000 | -11.4% | 39,288 | -8.0% | 0.01% | -33.3% |
| Q2 2016 | $613,000 | +18.1% | 42,705 | -1.6% | 0.01% | +12.5% |
| Q1 2016 | $519,000 | -4.9% | 43,419 | +5.8% | 0.01% | -27.3% |
| Q4 2015 | $546,000 | +10.8% | 41,033 | -10.6% | 0.01% | -8.3% |
| Q3 2015 | $493,000 | +183.3% | 45,897 | +112.5% | 0.01% | +140.0% |
| Q2 2015 | $174,000 | – | 21,597 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |